ArticleInternational journal of environmental research and public health2022
Comparing Environmental Policies to Reduce Pharmaceutical Pollution and Address Disparities.
Article in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.
- Facilitators for establishing a home-based medicine reverse logistic system in low- and middle-income countries - a scoping review.Frontiers in pharmacology · 2025Pooled it
- Risk governance of transgenic plants: bridging science, policy, and public trust.Transgenic research · 2026Review
- Hydrogeologic Drivers and Management Implications of PFAS, Nitrate, and Pharmaceuticals in Groundwater at a Karst Beneficial Reuse System.ACS ES&T water · 2026Article
- Assessing Knowledge, Attitudes, and Practices (KAP) related to green pharmacy among community and hospital pharmacists in Jordan.BMC medical education · 2026Article
- Drugs in the environment, viruses in the balance: a review of the untold nexus of pharmaceuticals and virology.Frontiers in public health · 2026Review
- Navigating Global Regulatory Divergence in Over-the-counter Drugs: Addressing Emerging Risks and Harmonization Challenges.Current drug research reviews · 2026Review
- Towards eco-friendly pharmaceuticals: Regulatory and policy approaches for sustainable medicines use.Exploratory research in clinical and social pharmacy · 2025Review
- UAE pharmacists' perceptions of the causes of unwanted or unused medications, their practices, and barriers to promoting safe medication disposal by the public.BMC public health · 2025Article
- Article
- Addressing Challenges in Antibiotic Access: Barriers, Implications and Strategies for Solution.Pharmaceutical medicine · 2024Review
- Pharmaceutical Pollutants: Ecotoxicological Impacts and the Use of Agro-Industrial Waste for Their Removal from Aquatic Environments.Journal of xenobiotics · 2024Review
- Modeling Predictors of Medication Waste Reduction Intention in Algeria: Extending the Theory of Planned Behavior.International journal of environmental research and public health · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pharmaceutical products, including active pharmaceutical ingredients and inactive ingredients such as packaging materials, have raised significant concerns due to their persistent input and potential threats to human and environmental health. Discourse on reducing pharmaceutical waste and subsequent pollution is often limited, as information about the toxicity of pharmaceuticals in humans is yet to be fully established. Nevertheless, there is growing awareness about ecotoxicity, and efforts to curb pharmaceutical pollution in the European Union (EU), United States (US), and Canada have emerged along with waste disposal and treatment procedures, as well as growing concerns about impacts on human and animal health, such as through antimicrobial resistance. Yet, the outcomes of such endeavors are often disparate and involve multiple agencies, organizations, and departments with little evidence of cooperation, collaboration, or oversight. Environmental health disparities occur when communities exposed to a combination of poor environmental quality and social inequities experience more sickness and disease than wealthier, less polluted communities. In this paper, we discuss pharmaceutical environmental pollution in the context of health disparities and examine policies across the US, EU, and Canada in minimizing environmental pollution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.